表紙:化合物管理の世界市場:2028年までの予測 - タイプ別(製品とサービス)、サンプルタイプ(バイオサンプルと化合物)、アプリケーション(遺伝子合成、バイオバンキングと創薬)、エンドユーザーと地域別の分析
市場調査レポート
商品コード
1218831

化合物管理の世界市場:2028年までの予測 - タイプ別(製品とサービス)、サンプルタイプ(バイオサンプルと化合物)、アプリケーション(遺伝子合成、バイオバンキングと創薬)、エンドユーザーと地域別の分析

Compound Management Market Forecasts to 2028 - Global Analysis By Type (Products and Services), Sample Type (Bio Samples and Chemical Compounds), Application(Gene Synthesis, Bio Banking and Drug Discovery), End User and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 175+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
化合物管理の世界市場:2028年までの予測 - タイプ別(製品とサービス)、サンプルタイプ(バイオサンプルと化合物)、アプリケーション(遺伝子合成、バイオバンキングと創薬)、エンドユーザーと地域別の分析
出版日: 2023年02月02日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、化合物管理の世界市場は2022年に4億3168万米ドルを占め、2028年には11億166万米ドルに達し、予測期間中にCAGR16.8%で成長すると予測されています。

化合物管理は、化合物管理とも呼ばれ、古くなった化学物質の更新、情報を含むデータベース、化学物質の取り出しによく関わるロボット、保管環境の品質管理など、化学物質ライブラリの管理と定義されます。研究用化合物の管理を支援するインフラとロジスティクスを提供します。新薬の開発を支援し、創薬プロセスにおける化合物の保管、準備、試験評価、調剤などのロジスティクスが含まれます。

Pharma R&D annual reviewによると、2020年のパイプラインは17,737品目で構成されていたが、現在は20,109品目まで増加しています。FDAの勧告によると、バイオテクノロジーと製薬会社は、研究開発プロセスにおけるバイオマーカーの発見と開発に大きく依存しています。

市場力学

促進要因

技術的進歩

化合物管理分野における人工知能やロボット技術の導入などの技術的進歩は、市場成長の主な要因となっています。大手製薬会社は、化合物サンプルの追加や保管場所からの取り出しなどの業務を処理するために、ロボット技術の助けを借りて化合物管理プロセスを自動化し、電子バーコードによって記録の保持を容易にしています。このようなことが市場成長の要因となっています。

抑制要因

莫大な投資

化合物管理の要件には大きな問題がありますが、これは協調的な努力によって克服されつつあります。化合物管理施設は、ハードウェアとソフトウェアの両方に多額の資金を必要とし、これには大量の在庫データベースに接続された新しい自動液体化合物貯蔵システムの建設が含まれます。したがって、これらの点が市場の成長を抑制しています。

機会

スピードと精度の維持

効果的な化合物管理システムは、スピードと精度のバランスを取る必要があります。ほとんどのコンパウンドハンドリングシステムは、問題の大半を占める人為的な操作を減らすことを目的としています。ラック、カルーセル、ロボットアームは、化合物の保管と移送を行う自動化合物バックアップ&リカバリーシステムで頻繁に使用されています。したがって、これらは市場の成長を後押しする要因となっています。

脅威

非効率的な管理

不適切な化合物管理は、ヘルスケア研究分野において様々な不都合な結果を招く可能性があります。不適切な化合物管理は、サンプルの損失や腐敗、不要な支出、その他医薬品研究開発プロセスを阻害する様々なボトルネックにつながります。したがって、これらの要因が市場の拡大を妨げているのです。

COVID-19の影響

COVID-19の発生により、さまざまなヘルスケア施設が影響を受けました。化合物管理市場にも大きな影響がありました。ロックダウンは物流と輸送を混乱させました。近い将来、ヘルスケア改革に不可欠なのは、技術の進歩、コストの抑制、アクセスの向上です。フロントライナーは、デジタルヘルスとテレヘルスです。パンデミックにより、遠隔地での診断、治療、相談の重要性が再認識されています。しかし、多くのヘルスケア従事者は電話やビデオ会議で作業している、このセグメントの成長は増加します。中程度の症状の患者のオンライン相談は、すでに患者の数に振り回されている病院の負担を大幅に軽減しています。

予測期間中、サービス分野が最大となる見込み

創薬活動の活発化、化合物管理サービスのニーズの高まり、創薬に関わるコスト削減ニーズの高まりなどから、サービス分野は有利な成長を遂げると予測されます。インフラを持たない中小企業の数が多いことも、さらに需要を向上させると予想され、セグメントの成長にプラスの影響を与える可能性があります。

予測期間中、バイオバンキング分野のCAGRが最も高くなると予想される

バイオバンキング分野は、生体材料の収集と保管に携わる組織の増加により、予測期間中に最も速いCAGRの成長を遂げると予測されます。また、個別化医療がますます重視されるようになり、バイオバンキングのニーズが高まっています。その上、研究をサポートするために使用される高品質のバイオ標本のニーズが増加することが予想されます。このように、上記の要因がこのセグメントの成長を支えていると予想されます。

最大シェアを誇る地域

アジア太平洋地域は、地域政府のイニシアティブ、創薬、官民共同研究などの継続的な研究により、予測期間中に最大の市場シェアを占めると予測されています。さらに、化合物管理サービスのアウトソーシングコストが低いこと、慢性疾患や感染症が多いことなどが、研究需要を喚起し、同地域の市場成長に寄与しています。

CAGRが最も高い地域

北米は、化合物管理のアウトソーシングの増加、医薬品開発ワークフローにおけるAIの利用の増加、およびバイオバンキングの現在の傾向により、予測期間において最も高いCAGRを有すると予測されます。さらに、疾患関連の罹患率と死亡率の上昇により、より多くの医薬品候補が特定され、この地域の成長を後押ししています。

主な発展

2022年6月、欧州の大手技術・製品開発会社TTPと、クリーンエネルギー用の次世代イオン交換膜とポリマーの設計・製造会社Ionomr Innovations Inc.が、大量生産向けに設計した新しいグリーン水素電解槽の実証に共同で取り組むと発表しました。

2021年2月、SPT Labtechは、自動サンプル管理の能力を強化するため、ロボティクス自動化プロバイダーのBioMicroLabの買収を発表しました。

本レポートが提供する内容

  • 地域レベルおよび国レベルセグメントの市場シェア評価
  • 新規参入企業への戦略的提言
  • 2020年、2021年、2022年、2025年、2028年の市場データを網羅
  • 市場動向(促進要因・制約要因・機会・脅威・課題・投資機会・推奨事項)
  • 市場推定に基づく、主要ビジネスセグメントにおける戦略的推奨事項
  • 主要な共通トレンドをマッピングした競合情勢
  • 詳細な戦略、財務、最近の開発状況を含む企業プロファイル
  • 最新の技術的進歩をマッピングしたサプライチェーン動向

無料カスタマイズサービス

本レポートをご購読のお客様には、以下のカスタマイズオプションのいずれかを無償でご提供いたします。

  • 企業プロファイル
    • 追加市場プレイヤーの包括的なプロファイリング(最大3社まで)
    • 主要プレイヤーのSWOT分析(3社まで)
  • 地域別セグメンテーション
    • お客様のご希望に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによります。)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要プレイヤーのベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査情報源
    • 1次調査情報源
    • 2次調査情報源
    • 仮定

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • アプリケーション分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターズファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の化合物管理市場:タイプ別

  • 製品
    • 自動リキッドハンドリングシステム
    • 自動合成システム
  • サービス

第6章 世界の化合物管理市場:サンプルタイプ別

  • バイオサンプル
  • 化学物質

第7章 世界の化合物管理市場:用途別

  • 遺伝子合成
  • バイオバンキング
  • 創薬

第8章 世界の化合物管理市場:エンドユーザー別

  • バイオ医薬品
  • 医薬品
  • 受託調査機関(CRO)

第9章 世界の化合物管理市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイル

  • BioAscent
  • Brooks Life Sciences
  • Hamilton Company
  • Titian Software Limited
  • LiCONiC AG
  • Evotec
  • Azenta US, Inc.
  • Tecan Trading AG
  • Beckman Coulter, Inc
  • SPT Labtech LTD.
  • ACompound ManagementAM S.p.A.
  • Labcyte
  • Biosero
  • Wuxi Apptec
  • TTP Group
  • Frontier Scientific
  • Icagen, Inc
図表

List of Tables

  • 1 Global Compound Management Market Outlook, By Region (2020-2028) ($MN)
  • 2 Global Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 3 Global Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 4 Global Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 5 Global Compound Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 6 Global Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 7 Global Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 8 Global Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 9 Global Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 10 Global Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 11 Global Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 12 Global Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 13 Global Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 14 Global Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 15 Global Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 16 Global Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 17 Global Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • 18 North America Compound Management Market Outlook, By Country (2020-2028) ($MN)
  • 19 North America Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 20 North America Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 21 North America Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 22 North America Compound Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 23 North America Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 24 North America Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 25 North America Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 26 North America Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 27 North America Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 28 North America Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 29 North America Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 30 North America Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 31 North America Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 32 North America Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 33 North America Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 34 North America Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • 35 Europe Compound Management Market Outlook, By Country (2020-2028) ($MN)
  • 36 Europe Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 37 Europe Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 38 Europe Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 39 Europe Compound Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 40 Europe Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 41 Europe Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 42 Europe Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 43 Europe Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 44 Europe Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 45 Europe Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 46 Europe Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 47 Europe Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 48 Europe Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 49 Europe Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 50 Europe Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 51 Europe Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • 52 Asia-Pacific Compound Management Market Outlook, By Country (2020-2028) ($MN)
  • 53 Asia-Pacific Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 54 Asia-Pacific Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 55 Asia-Pacific Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 56 Asia-Pacific Compound Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 57 Asia-Pacific Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 58 Asia-Pacific Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 59 Asia-Pacific Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 60 Asia-Pacific Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 61 Asia-Pacific Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 62 Asia-Pacific Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 63 Asia-Pacific Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 64 Asia-Pacific Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 65 Asia-Pacific Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 66 Asia-Pacific Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 67 Asia-Pacific Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 68 Asia-Pacific Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • 69 South America Compound Management Market Outlook, By Country (2020-2028) ($MN)
  • 70 South America Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 71 South America Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 72 South America Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 73 South America Compound Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 74 South America Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 75 South America Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 76 South America Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 77 South America Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 78 South America Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 79 South America Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 80 South America Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 81 South America Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 82 South America Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 83 South America Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 84 South America Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 85 South America Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • 86 Middle East and Africa Compound Management Market Outlook, By Country (2020-2028) ($MN)
  • 87 Middle East and Africa Compound Management Market Outlook, By Type (2020-2028) ($MN)
  • 88 Middle East and Africa Compound Management Market Outlook, By Products (2020-2028) ($MN)
  • 89 Middle East and Africa Compound Management Market Outlook, By Automated Liquid Handling Systems (2020-2028) ($MN)
  • 90 Middle East and Africa Management Market Outlook, By Automated Compound Systems (2020-2028) ($MN)
  • 91 Middle East and Africa Compound Management Market Outlook, By Services (2020-2028) ($MN)
  • 92 Middle East and Africa Compound Management Market Outlook, By Sample Type (2020-2028) ($MN)
  • 93 Middle East and Africa Compound Management Market Outlook, By Bio Samples (2020-2028) ($MN)
  • 94 Middle East and Africa Compound Management Market Outlook, By Chemical Compounds (2020-2028) ($MN)
  • 95 Middle East and Africa Compound Management Market Outlook, By Application (2020-2028) ($MN)
  • 96 Middle East and Africa Compound Management Market Outlook, By Gene Synthesis (2020-2028) ($MN)
  • 97 Middle East and Africa Compound Management Market Outlook, By Bio Banking (2020-2028) ($MN)
  • 98 Middle East and Africa Compound Management Market Outlook, By Drug Discovery (2020-2028) ($MN)
  • 99 Middle East and Africa Compound Management Market Outlook, By End User (2020-2028) ($MN)
  • 100 Middle East and Africa Compound Management Market Outlook, By Biopharmaceutical (2020-2028) ($MN)
  • 101 Middle East and Africa Compound Management Market Outlook, By Pharmaceutical (2020-2028) ($MN)
  • 102 Middle East and Africa Compound Management Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
目次
Product Code: SMRC22367

According to Stratistics MRC, the Global Compound Management Market is accounted for $431.68 million in 2022 and is expected to reach $1101.66 million by 2028 growing at a CAGR of 16.8% during the forecast period. Compound management, also referred to as compound control, is defined as the management of chemical libraries, including renewal of outdated chemicals, databases containing the information, robotics often involved in fetching chemicals, and quality control of the storage environment. It provides the infrastructure and logistics that aid in managing research compounds. It aids in the development of new drugs, and entails the logistics of storing, preparing, and evaluating compounds for testing as well as dispensing them during the drug discovery process.

According to Pharma R&D annual review, the pipeline consisted of 17,737 drugs in 2020, now the number of drugs in the pipeline rose to 20,109. According to FDA recommendations, biotechnology and pharmaceutical companies depend significantly on the discovery and development of biomarkers in R&D processes.

Market Dynamics:

Driver:

Technological Advancements

Technological advancements such as introduction of artificial intelligence and robotic technology in the field of compound management is a major factor driving the market growth. Large pharmaceutical companies automate compound management process with the help of robotics technology for handling the duties of adding and removing compound samples from storage and electronic barcodes facilitate record keeping. Hence, these are the factors fueling the growth of the market.

Restraint:

Huge Investments

The requirement for compound management presents significant problems, which are being overcome by coordinated efforts. A compound management facility requires significant financial outlays for both hardware and software, including the construction of new automated liquid compound storage systems connected to a substantial inventory database. Thus, these aspects are restraining the growth of the market.

Opportunity:

Maintaining speed and accuracy

An effective compound management system must strike a balance between speed and accuracy. Most compound handling systems aim to reduce human handling because it is the source of the vast majority of problems. Racks, carousels, and robotic arms are frequently used in automated compound backup and recovery systems to store and transfer compounds. Therefore, these are the factors boosting the market growth.

Threat:

Inefficient management

Improper compound management could potentially lead to various unfavourable consequences in the healthcare research sector. Inadequate compound management leads to loss or spoilage of samples, unwanted expenditure, and various other bottlenecks that hamper the drug research and development process. Hence, these factors are hindering the expansion of the market.

COVID-19 Impact

Various healthcare facilities were affected due to the outbreak of COVID-19. There was a huge impact on Compound Management Market as well. Lockdowns disrupted logistics and transportation. An integral part of healthcare reforms in near future will be technological progress, cost containment, and increased access. The front liners are digital health and telehealth. The importance of remote diagnosis, care, and consultation is re-emphasized due to the pandemic. However, many healthcare workers are working on telephone calls and video conferencing, this segment growth will increase. Online consultation of patients with moderate symptoms has greatly reduced the burden on hospitals already swamped by counts of the patients.

The service segment is expected to be the largest during the forecast period

The service segment is estimated to have a lucrative growth, due to the rise in drug discovery activities, the growing need to manage the compound management services, and the increasing need to save costs associated with drug discovery. A significant number of small and medium-sized companies lacking infrastructure is further expected to improve the demand and thus is likely to have a positive impact on the segment growth.

The bio banking segment is expected to have the highest CAGR during the forecast period

The bio banking segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing number of organizations involved in the collection and storage of biomaterials. In addition, an increasing emphasis on personalized medicine is driving the need for bio banking. Besides, the need for quality bio specimens that are used to support research is expected to increase. Thus, the abovementioned factors are anticipated to support the growth of the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to continuous research in regional government initiatives, pharmaceutical discovery, and private-public collaborations. Furthermore, the low cost of outsourcing compound management services and the high prevalence of chronic and infectious diseases in the region are driving the demand for research, thus contributing to the regional market growth.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to rising outsourcing of compound management, increasing use of AI in drug development workflow, and the current trend of biobanking. Furthermore, the rise in disease-related morbidity and mortality has resulted in the identification of more drug candidates, fueling growth in this region.

Key players in the market

Some of the key players profiled in the Compound Management Market include BioAscent, Brooks Life Sciences, Hamilton Company, Titian Software Limited, LiCONiC AG, Evotec, Azenta US, Inc., Tecan Trading AG, Beckman Coulter, Inc, SPT Labtech LTD., AXXAM S.p.A., Labcyte , Biosero, Wuxi Apptec, TTP Group, Frontier Scientific and Icagen, Inc.

Key Developments:

In June 2022, TTP Europe's leading technology and product development company and Ionomr Innovations Inc., designer and manufacturer of next-generation ion-exchange membranes and polymers for clean energy, announced they are joining forces to demonstrate a new green hydrogen electrolyzer designed for mass production.

In February 2021, SPT Labtech announced the acquisition of BioMicroLab, a robotics automation provider, to strengthen its capabilities in automatic sample management.

Types Covered:

  • Products
  • Services

Sample Types Covered:

  • Bio Samples
  • Chemical Compounds

Applications Covered:

  • Gene Synthesis
  • Bio Banking
  • Drug Discovery

End Users Covered:

  • Biopharmaceutical
  • Pharmaceutical
  • Contract Research Organizations (CROs)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Compound Management Market, By Type

  • 5.1 Introduction
  • 5.2 Products
    • 5.2.1 Automated Liquid Handling Systems
    • 5.2.2 Automated Compound Systems
  • 5.3 Services

6 Global Compound Management Market, By Sample Type

  • 6.1 Introduction
  • 6.2 Bio Samples
  • 6.3 Chemical Compounds

7 Global Compound Management Market, By Application

  • 7.1 Introduction
  • 7.2 Gene Synthesis
  • 7.3 Bio Banking
  • 7.4 Drug Discovery

8 Global Compound Management Market, By End User

  • 8.1 Introduction
  • 8.2 Biopharmaceutical
  • 8.3 Pharmaceutical
  • 8.4 Contract Research Organizations (CROs)

9 Global Compound Management Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BioAscent
  • 11.2 Brooks Life Sciences
  • 11.3 Hamilton Company
  • 11.4 Titian Software Limited
  • 11.5 LiCONiC AG
  • 11.6 Evotec
  • 11.7 Azenta US, Inc.
  • 11.8 Tecan Trading AG
  • 11.9 Beckman Coulter, Inc
  • 11.10 SPT Labtech LTD.
  • 11.11 ACompound ManagementAM S.p.A.
  • 11.12 Labcyte
  • 11.13 Biosero
  • 11.14 Wuxi Apptec
  • 11.15 TTP Group
  • 11.16 Frontier Scientific
  • 11.17 Icagen, Inc